The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients.
 
Tuyen Hoang
No Relationships to Disclose
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - Array BioPharma; Eisai; Exelixis; Genentech/Roche
Speakers' Bureau - Amgen; Eisai; Exelixis; Genentech/Roche; ipsen; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst)
 
Ariceli Alfaro
No Relationships to Disclose
 
Jasmine Huynh
No Relationships to Disclose
 
Jingran Ji
No Relationships to Disclose
 
Andrew H. Ko
Honoraria - Clinical Care Options; Dava Oncology; Elsevier; OncLive; PER; Pharmatecture; PlatformQ Health; Research to Practice; Xcenda
Consulting or Advisory Role - ERYTECH Pharma; Gilead Sciences; Gritstone Bio; Imugene; MORE Health; SynCoreBio
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; Eisai; Exelixis; Ipsen; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Darryl Hiyama
No Relationships to Disclose